FDA sets review date for SpinalMotion's artificial disc

05/8/2013 | MassDevice.com (Boston)

An FDA panel will meet on July 24 to evaluate SpinalMotion's premarket approval application for the Kineflex/C system. The metal-on-metal total disc replacement device, which is already available in Europe, is intended for one-level repair of the intervertebral disc in patients who have undergone single-level discectomy for lumbar degenerative disc disease.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC